Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than the traditional "buying low and selling high" approach, aiming for quicker profits [1] Group 1: Momentum Investing Characteristics - Fast-moving trending stocks can be difficult to enter at the right time, as they may lose momentum if future growth does not justify their high valuations [2] - Investing in bargain stocks that have recently shown price momentum can be a safer strategy, utilizing tools like the Zacks Momentum Style Score to identify potential opportunities [3] Group 2: Bionano Genomics, Inc. (BNGO) Analysis - BNGO has shown a four-week price change of 37.1%, indicating strong recent price momentum and growing investor interest [4] - Over the past 12 weeks, BNGO's stock gained 9.3%, with a beta of 2.25, suggesting it moves 125% higher than the market in either direction [5] - BNGO has a Momentum Score of A, indicating a favorable time to invest based on momentum [6] Group 3: Earnings Estimates and Valuation - An upward trend in earnings estimate revisions has contributed to BNGO earning a Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - BNGO is trading at a Price-to-Sales ratio of 0.68, suggesting it is undervalued, as investors pay only 68 cents for each dollar of sales [7] Group 4: Additional Investment Opportunities - Besides BNGO, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - The Zacks Premium Screens offer over 45 different strategies to help identify potential winning stocks based on various investing styles [9]